Updates from The Motley Fool

Latest updates on NewLink Genetics Corporation from Fool.com.

Stock Performance

NLNK vs. S&P 500 | 2 Year Performance
NLNK 1-Day Stock Chart
NLNK 5-Day Stock Chart
NLNK 1-Month Stock Chart
NLNK 3-Month Stock Chart
NLNK 6-Month Stock Chart
NLNK 1-Year Stock Chart
NLNK 2-Year Stock Chart
NLNK 5-Year Stock Chart
View Interactive NLNK Charts
Sponsored by

Key Data Points

Primary metrics and data points about NewLink Genetics Corporation .
Current Price: $10.72
Prev Close: $10.58
Open: $10.73
Bid: $7.01
Ask: $10.85
Day's Range: $10.42 - $10.86
52wk Range: $9.23 - $56.16
Volume: 447,126
Avg Vol 902,082
Market Cap: $308.44M
P/E (ttm): -4.10
EPS (ttm): -$2.58
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about NewLink Genetics Corporation .
CAPS Rating 2 out of 5
47 Outperform
14 Underperform
CAPS All Stars
7 Outperform
6 Underperform

How do you think NewLink Genetics Corporation will perform against the market?

You pick for NewLink Genetics Corporation is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS

CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Dr. Charles J. Link, CEO

56% Approve

Based on 2 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for NewLink Genetics Corporation .

NewLink Genetics Corporation is a biopharmaceutical company focused on discovering developing and commercializing novel immunotherapeutic products to improve cancer treatment options for patients and physicians.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers